Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)

6.11
Delayed Data
As of Jun 22
 +0.11 / +1.83%
Today’s Change
5.53
Today|||52-Week Range
7.96
-16.98%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$94.3M

Company Description

Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of brands for the hospital acute care, gastroenterology, and oncology. Its product brands include acetadote, caldolor, kristalose, hepatoren, omeclamox, vaprisol, boxaban, vasculan, ethyol, portaban, and totect. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.

Contact Information

Cumberland Pharmaceuticals, Inc.
2525 West End Avenue
Nashville Tennessee 37203
P:(615) 255-0068
Investor Relations:

Employees

Shareholders

Mutual fund holders9.05%
Individual stakeholders51.74%
Other institutional25.60%

Top Executives

A. J. KazimiChairman & Chief Executive Officer
Leo B. PavlivEVP-Operations & Chief Development Officer
Michael P. BonnerCFO, Senior Director-Finance & Accounting
Amy Dix RockSenior Director-Regulatory & Scientific Affairs
James L. HermanChief Compliance Officer & Senior Vice President